Bolt Biotherapeutics Presents New Preclinical Data on Three Pipeline Programs at Society for Immunotherapy of Cancer (SITC) Annual Meeting

NEXT STORY
Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) Annual Meeting
PREV STORY
Global $32.67 Billion Bioethanol Yeast Market to 2028: Cleaning & Disinfection Segment Projected to Register the Fastest CAGR Over Forecast Period
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Study Demonstrates the Ability of myPath® Melanoma to Accurately Classify Lesions Ruled Indeterminate by Standard Pathological Assessment

author_avatar
NASDAQ Market News

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research

MALVERN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue ...

author_avatar
NASDAQ Market News

Medivir investigates possible corporate split and separate listing of commercial operations

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Board of ...

author_avatar
NASDAQ Market News